NCT00447941View on ClinicalTrials.gov

Safety, PK and PD Study in Healthy Male Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

SCA-136

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00447941 - Safety, PK and PD Study in Healthy Male Japanese Subjects | Biotech Hunter | Biotech Hunter